Lantern Pharma Inc. (LTRN) › EPS (Diluted)Lantern Pharma Inc. (LTRN) — EPS (Diluted)Annual figures by period end, from SEC filings.2022-12-31: $-1.312023-12-31: $-1.472024-12-31: $-1.932025-12-31: $-1.57$-1.572022-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-1.57—2026-03-30From 2025-01-012024-12-31$-1.93—2026-03-30From 2024-01-012023-12-31$-1.47—2025-03-27From 2023-01-012022-12-31$-1.31—2024-03-18From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)